title: [Overview of regulatory aspects guiding tablet scoring].
abstract: Tablet scoring is a controversial but common practice used to adjust doses, facilitate drug intake, or lower the cost of drug treatment, especially in children and the elderly. The risks of tablet scoring are mainly related to inaccuracies in the resulting dose and stability problems. The aim of this article is to provide an overview of worldwide guidelines regarding tablet scoring. We found that regulatory health agencies in Mercosur countries as well as other South American countries do not have published standards addressing tablet splitting. Among the surveyed health agencies, the Food and Drug Administration (FDA) in the United States is the only one to present standards, ranging from splitting instructions to regulation of the manufacturing process. The concept of functional scoring implemented by the FDA has introduced some level of guarantee as to the ability of tablets to be split. In conclusion, technical and scientific bases are still insufficient to guide health rules on this subject, making the decision on scoring, in certain situations, random and highly risky to public health. The need for more detailed regulation is vital to ensure the safety of tablet medications.
authors.forename: Maíra Teles
authors.initials: MT
authors.lastname: Teixeira
authors.forename: Lívia Cristina Lira
authors.initials: LC
authors.lastname: Sá-Barreto
authors.forename: Dayde Lane Mendonça
authors.initials: DL
authors.lastname: Silva
authors.forename: Marcílio Sergio Soares
authors.initials: MS
authors.lastname: Cunha-Filho
mesh_terms: D017408:Guidelines as Topic; D038622:Internationality; D007880:Legislation, Drug; D012015:Reference Standards; D013020:South America; D013607:Tablets / Q000008:administration & dosage*
chemical_list: D013607:Tablets